Clinical Trial Update: Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial comparing buccal versus vaginal misoprostol for management of early pregnancy loss has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Abortion in the First Trimester

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: University of California, San Diego | Conditions: Spontaneous Abortion in First Trimester | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-08-15